Polpharma API

Polish CDMO and API manufacturer for small-molecule active pharmaceutical ingredients, including high-potency APIs. Part of Polpharma Group, one of the largest pharma companies in Poland. FDA-approved and cGMP-compliant production site since 1951. Offers custom API development and manufacturing from clinical to in-market supply. Note: primarily small-molecule APIs; no specific peptide API manufacturing capability published.

Directory assessment: Polpharma API is listed as a CDMO in the peptide supply chain, serving Europe markets from Poland. As a direct manufacturer, this supplier controls its own production process from synthesis through purification and quality control release testing. This profile lists 1 source for reference. This supplier has a moderate confidence score — buyers should perform additional due diligence before engaging.